Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020481

VP Finance & Operations sold 224 shares at $0.35 ($78)

  • VP Finance & Operations acquired 1,516 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mitrano Richard J. · VP Finance & Operations

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-05 Exercise or conversion : show line 1 in the form 10b5-1 +758 31,753 D
2023-07-06 Sale : show line 2 in the form 10b5-1 −224 $0.35 $78 31,529 D
2023-07-06 Exercise or conversion : show line 3 in the form 10b5-1 +758 32,287 D
Open-market sales · 224 sh · avg $0.35 · $78

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2023-07-05 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit −758 758 24,242 D
2023-07-06 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit −758 758 23,484 D
Loading xslF345X04/form4.xml…